Archeon Medical Series A (2026)
Archeon Medical raised $9 million (€7.5 million) in a Series A round, announced on 2026-10-06. The round was led by Newfund.
- Company
- Archeon Medical
- Round type
- Series A
- Date
- 2026-10-06
- Amount
- $9M
- Industry
- medical devices, emergency ventilation monitoring
- Location
- Besançon, France
Summary
Archeon Medical announced $9 million (€7.5 million) in Series A equity funding on 2026-10-06. Newfund led the round through its HEKA fund. New investors Eiffel Investment Group and UI Investissement (through its OSER BFC fund) joined existing investors Majycc Innovation Santé and Karot Capital.
Investors
Lead
- Newfund lead
Participating
- Eiffel Investment Group participant
- UI Investissement participant
- Majycc Innovation Santé participant
- Karot Capital participant
Sources
Last verified:
- https://ala.associates/funding/archeon-medical-secures-9m-e7-5m-series-a-to-advance-clinical-validation-of-ventilation-system-for-cardiac-arrest-patients/
Type: funding announcement. Accessed 2026-10-06.
Company press release dated October 6, 2026, published by Andrew Lloyd and Associates. Announces $9 million (€7.5M) in Series A equity funding led by Newfund through its HEKA fund. - https://dealroom.co/news/160232-archeon-medical-raises-7-5-million-to-push-eolife-into-us-market/
Type: other verified public source. Accessed 2026-10-06.
Dealroom News item dated 2026-10-06. Confirms the €7.5 million Series A, the Newfund lead and the participants, and names CEO Alban de Luca. - https://www.estrepublicain.fr/economie/2026/10/06/la-start-up-bisontine-archeon-medical-leve-7-5-millions-d-euros-pour-se-developper-aux-etats-unis
Type: reputable publication. Accessed 2026-10-06.
L'Est Républicain article dated 2026-10-06, in French. Source of the 2018 founding year and the US subsidiary in New York. - https://www.finsmes.com/2026/10/archeon-medical-raises-9m-in-series-a-funding.html
Type: reputable publication. Accessed 2026-10-06.
FinSMEs article dated 2026-10-06. Confirms the amount, stage, lead and participants.